Adar1 Capital Management, LLC Acadia Pharmaceuticals Inc Transaction History
Adar1 Capital Management, LLC
- $615 Billion
- Q3 2024
A detailed history of Adar1 Capital Management, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 23,100 shares of ACAD stock, worth $431,046. This represents 0.06% of its overall portfolio holdings.
Number of Shares
23,100
Previous 1,300
1676.92%
Holding current value
$431,046
Previous $21.1 Million
1581.79%
% of portfolio
0.06%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ACAD
# of Institutions
279Shares Held
156MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$800 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$258 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$256 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$225 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$111 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.02B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...